Linda Loren-Gulla Hired as Vice President of Marketing to Lead Celsius Expansion
Boca Raton, FL (August 31, 2015) – Celsius Holdings, Inc., the creator and marketer of Celsius®, the leading fat burning beverage backed by clinical science, has appointed Linda Loren-Gulla as Vice President of Marketing. As part of the executive team, Loren-Gulla will oversee the Celsius global corporate brand, driving the company’s positioning, branding and identity, marketing campaigns, advertising, and social media platforms to ensure strong connections with customers and partners, all while strengthening Celsius’ position as a leader in the specialty beverage market.
“Linda joins our team with a clear vision of where the brand needs to go, as well as the skills needed to develop the strategy that will make that vision achievable,” said Gerry David, President and CEO of Celsius. “Her leadership, coupled with her tenured experience in marketing and branding of health-focused consumer product goods, will further reinforce Celsius as a leading competitor within the space across the U.S. as well as globally.”
After studying consumer science at Montclair University in New Jersey, Loren-Gulla became a certified nutritional educator and used her background in consumer product goods to develop an extensive resume of over 20 years experience delivering visionary strategic development and operational excellence in the areas of sales, marketing, branding and consumer engagement. Prior to launching her tenure with Celsius, she served as the Vice President of Marketing for Genius Central, Inc., a leading provider of technology and marketing solutions serving more than 3,500 retailers and 2.5 million consumers. In addition, she has held executive level marketing and sales roles with nationally recognized companies such as Oragenics Inc., a leader in probiotic research and consumer products; Växa International, a leading manufacturer of homeopathic medicines, herbal products, vitamins and supplements; and Sykes Enterprises, a global leader in providing customer contact management solutions and services in the business process outsourcing arena.
“The mission of Celsius is to help individuals reach their true potential by utilizing products and services that are based on scientific advancements and enable a healthier lifestyle. This is a mission I am aligned with personally and professionally which is why working with the brand is a natural transition,” said Linda Loren-Gulla, Vice President of Marketing at Celsius. “I will help Celsius continue to see brand growth by leveraging my previous experience and leadership in consumer goods marketing, and providing innovative strategies that a functional beverage company, like Celsius, requires to expand aggressively both domestically and internationally.”
Celsius’ great tasting, fat burning, ready-to-drink beverages provide clinically-proven health benefits to consumers, are certified gluten-free, contain no sugar, no high fructose corn syrup, no aspartame, or no preservatives, flavors, or colors, and are low in sodium. Celsius® is available in a variety of delicious flavors, carbonated and non-carbonated, including Sparkling Orange, Sparkling Wild Berry, Sparkling Cola, Raspberry Acai Green Tea and Peach Mango Green Tea.
About Celsius Holdings, Inc.
Celsius Holdings Inc. (OTC: CELH) is a science-based functional beverage company founded in April 2004, and is the world’s first and only negative calorie, leading fat burning drink. Backed by multiple clinical studies, drinking Celsius before activity has been proven to help burn up to 93% more body fat and 100 calories or more per serving. In addition, Celsius helps to boost metabolism, provides clean energy and accelerates results of any health promoting program. It comes in five delicious flavors, carbonated and non-carbonated, and is also available in powder stick packets that can be mixed with water. Celsius contains no sugar, no high-fructose corn syrup, no aspartame, no preservatives, no artificial flavors or colors, is gluten free and low in sodium. The first clinical study was published in 2007. Five additional published studies from the University of Oklahoma were conducted over the next five years. For more information, please visit www.celsius.com.
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings’ future results of operations and/or financial position, or state other forward-looking information. In some cases you can identify these statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will,” “would,” or similar words. You should not rely on forward-looking statements since Celsius Holdings’ actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.